Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 1,448 | 2,231 | 2,215 | 2,124 | 1,912 |
| Gross Profit | 1,448 | 2,231 | 2,215 | 2,124 | 1,912 |
| Operating Expenses | 2,050 | 2,792 | 2,926 | 3,133 | 3,103 |
| Operating Income | -602 | -561 | -711 | -1,009 | -1,191 |
| Interest Expense | 0 | 0 | 0 | 15 | 0 |
| Other Income | 3,666 | 3,324 | 3,688 | -1,122 | 7,484 |
| Pre-tax Income | 3,064 | 2,763 | 2,977 | -2,146 | 6,293 |
| Net Income Continuous | 3,064 | 2,763 | 2,977 | -2,146 | 6,293 |
| Net Income | $3,064 | $2,763 | $2,977 | $-2,146 | $6,293 |
| EPS Basic Total Ops | 0.02 | 0.02 | 0.02 | -0.03 | 0.10 |
| EPS Basic Continuous Ops | 0.05 | 0.05 | 0.05 | -0.03 | 0.10 |
| EPS Diluted Total Ops | 0.02 | 0.00 | -0.01 | -0.01 | 0.07 |
| EPS Diluted Continuous Ops | 0.05 | 0.04 | 0.04 | 0.03 | 0.07 |
| EBITDA(a) | $-602 | $-561 | $-711 | $-1,009 | $-1,191 |